TX HHS Form 4008. Informed Consent for Opiate Use Disorder Individuals Seeking Treatment Youths Ages 13 to 18

The TX HHS Form 4008, Informed Consent for Opiate Use Disorder Individuals Seeking Treatment - Youths Ages 13 to 18, is a crucial document that helps solve the problem of obtaining informed consent from youths with opioid/opiate use disorder seeking treatment. This form is typically used in situations where youths are seeking medication-assisted treatment or withdrawal management and drug treatment. The form is usually filled out by healthcare professionals or treatment centers providing services to these individuals.

The form outlines four options for treatment, including medication-assisted treatment with methadone or buprenorphine, which requires a daily dose of medication and participation in substance use disorder counseling. Other key features include the requirement for two previous treatment attempts for youths under 18, written consent from a parent or legal guardian, and review of admission drug test results by a physician before initial dosing. The form also emphasizes the importance of voluntary participation and understanding of informed consent.

The benefits of medication-assisted treatment include receiving a steady dose of medication, eliminating cravings, and being able to return to normal functioning. However, it is essential to note that this treatment is not short-term and may require taking medication for a year or more. The form also highlights the risks associated with sudden cessation of medication, mixing with illicit drugs, and consuming other opiates while on treatment. By understanding these benefits and risks, individuals can make informed decisions about their treatment options.

• This form is used for youths ages 13 to 18 seeking treatment for opioid/opiate use disorder.
• It outlines four treatment options: medication-assisted treatment with methadone or buprenorphine, withdrawal management and drug treatment, and two other options.
• The form requires written consent from a parent or legal guardian for youths under 18 and review of admission drug test results by a physician before initial dosing.